APA (7th ed.) Citation

Patel, P. J., Jayaram, H., Eleftheriadou, M., Vazquez-Alfageme, C., Islam, N., Rubin, G. S., . . . Esposti, S. D. (2020). Individualizing Therapy for Neovascular Age-Related Macular Degeneration with Aflibercept (VITAL): A Two-Year Prospective, Interventional Single-Centre Trial. Adis, Springer Healthcare.

Chicago Style (17th ed.) Citation

Patel, Praveen J., et al. Individualizing Therapy for Neovascular Age-Related Macular Degeneration with Aflibercept (VITAL): A Two-Year Prospective, Interventional Single-Centre Trial. Adis, Springer Healthcare, 2020.

MLA (9th ed.) Citation

Patel, Praveen J., et al. Individualizing Therapy for Neovascular Age-Related Macular Degeneration with Aflibercept (VITAL): A Two-Year Prospective, Interventional Single-Centre Trial. Adis, Springer Healthcare, 2020.